Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Journal of Cardiac Failure|January 11, 2024
Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF TrialMarat Fudim, Sheldon E Litwin, Barry A Borlaug, et al.
NPJ Digital Medicine|February 18, 2025
Identification of digital twins to guide interpretable AI for diagnosis and prognosis in heart failureFeng Gu, Andrew J Meyer, Filip Ježek, et al.
JACC. Advances|August 16, 2023
Assessment and Management of Older Adults Undergoing PCI, Part 1: A JACC: Advances Expert PanelMichael G Nanna, Nadia R Sutton, Ajar Kochar, et al.
The American Journal of Cardiology|October 27, 2019
Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial)Thomas C Hanff, David M Kaye, Christopher S Hayward, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2020
Moderate-Intensity Exercise and High-Intensity Interval Training Affect Insulin Sensitivity Similarly in Obese AdultsBenjamin J Ryan, Michael W Schleh, Cheehoon Ahn, et al.
Circulation|November 17, 2017
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled TrialTed Feldman, Laura Mauri, Rami Kahwash, et al.
Circulation|March 24, 2020
Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group SummarySanjiv J Shah, Barry A Borlaug, Dalane W Kitzman, et al.
JAMA Cardiology|April 17, 2024
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical TrialRavi B Patel, Frank E Silvestry, Jan Komtebedde, et al.
European Heart Journal|August 9, 2014
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypesMichele Senni, Walter J Paulus, Antonello Gavazzi, et al.
Journal of the American College of Cardiology|July 9, 2016
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)Mathew S Maurer, Mazen Hanna, Martha Grogan, et al.
Pageof 14